Most Read Articles
Stephen Padilla, 05 Jan 2018
The addition of an antihypertensive drug from a new class to a patient’s regimen results in huge decreases in systolic blood pressure (SBP) and major cardiovascular (CV) events among those at high risk for CV events but without diabetes, suggests a recent study. Its effects on SBP remain large and similar in magnitude across all levels of baseline drug use and all subgroups of patients.
Pearl Toh, 3 days ago
A study finds no evidence that using pharmaceutical aids alone for smoking cessation helps improve the chances of successful quitting despite promising results in previous randomized trials and routine prescription of such drugs to help quit smoking.
04 Jan 2018
Thromboembolism is a major cause of death in patients with cancer, which is why clinicians should check for the symptoms of thromboembolic events right from the initial stages of bevacizumab treatment, suggests a recent study.
04 Jan 2018
Statins appear to reduce the severity of acute pancreatitis (AP), as demonstrated by a decrease in overall incidence of multisystem organ failure (MSOF), according to a study.

High opioid users more satisfied with care

4 days ago
The opioid epidemic in the US has presented a complicated moral dilemma to doctors when treating potential drug abusers.

In patients with musculoskeletal conditions, opioid prescriptions result in better patient satisfaction, a recent cross-sectional study has found.

The researchers evaluated satisfaction with care of 19,566 adult patients with musculoskeletal problems and found that opioid use resulted in a 32-percent increase in the odds of high care satisfaction (adjusted odds ratio [OR], 1.32; 95 percent CI, 1.18–1.49). The rate of opioid prescription was 13.1 percent, with 2,564 users reported.

Compared with nonusers, opioid users tended to have poorer overall health. Scores in the physical (33.3 vs 46.0) and mental (44.4 vs 49.9) component summaries of the 12-item Short Form health survey were significantly lower in users than in nonusers (p<0.001 for both). There was also a significantly greater proportion of users that rated their health as fair or poor (p<0.001).

When the participants were stratified according to levels of opioid use, the unadjusted models showed that moderate users (28.9 percent) reported significantly better satisfaction.

However, after complete adjustments for covariates, both moderate (adjusted OR, 1.55; 1.29–1.86) and heavy (41.9 percent; adjusted OR, 1.43; 1.20–1.70) users reported significantly higher satisfaction.

Moreover, each increase in the categories of opioid use level (none, low, moderate and heavy) resulted in a significant 15-percent increase in the likelihood of being in the highest quartile of satisfaction scores (p<0.001 for trend).

To measure satisfaction, the researchers accessed the participants’ responses in the Consumer Assessment of Health Plans Survey, which the participants accomplished once a year. Logistic regression analyses were performed to assess the relationship between satisfaction with care and opioid use.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Stephen Padilla, 05 Jan 2018
The addition of an antihypertensive drug from a new class to a patient’s regimen results in huge decreases in systolic blood pressure (SBP) and major cardiovascular (CV) events among those at high risk for CV events but without diabetes, suggests a recent study. Its effects on SBP remain large and similar in magnitude across all levels of baseline drug use and all subgroups of patients.
Pearl Toh, 3 days ago
A study finds no evidence that using pharmaceutical aids alone for smoking cessation helps improve the chances of successful quitting despite promising results in previous randomized trials and routine prescription of such drugs to help quit smoking.
04 Jan 2018
Thromboembolism is a major cause of death in patients with cancer, which is why clinicians should check for the symptoms of thromboembolic events right from the initial stages of bevacizumab treatment, suggests a recent study.
04 Jan 2018
Statins appear to reduce the severity of acute pancreatitis (AP), as demonstrated by a decrease in overall incidence of multisystem organ failure (MSOF), according to a study.